M

Active Director Director DIN 08524625
DIN 08524625 First appointment Jul 2019 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2019
Shareholding value •••• Premium profile

About Manonmani

Data last updated:

Manonmani is a Director at Marllon Healthcare Private Limited (since 2019). The company operates in Chemicals. Marllon Healthcare Private Limited reported revenue of ₹1.48 Cr (FY 2024).

DIN 08524625
Primary Designation Director
Industry Chemicals
First Appointment 30 Jul 2019
Oldest Company Age 7 yrs
Largest company Marllon Healthcare Private Limited · ₹1.48 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Marllon Healthcare Private Limited U24232TN2019PTC130810
Director30 Jul 20192019₹1.48 Cr (FY 2024)Active

Board colleagues of Manonmani

Directorship timeline

Open interactive timeline →
Marllon Healthcare Private Limited
Premium access

Shareholding and investment profile for Manonmani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manonmani

Manonmani currently holds 1 directorship: Marllon Healthcare Private Limited (Director, since 30 Jul 2019, revenue ₹1.48 Cr (FY 2024)).

Manonmani was first appointed on 30 Jul 2019 as Director at Marllon Healthcare Private Limited.

The current boards of Manonmani's companies include Kaliappan Sooriyaraj (Marllon Healthcare Private Limited), Kamaraj Jeyarani Siddharth (Marllon Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available